1669 |
Featured Lecture: The Fate of PCI for Multi-Vessel Disease in the Era of COURAGE, SYNTAX, FAME, and FREEDOM |
Seung-Jung Park |
May. 09. 13 |
1668 |
Counterpoint: Surgical AVR Remains the Procedure-of-Choice for Most AS Patients |
David Paul Taggart |
May. 09. 13 |
1667 |
Featured Lecture: TAVR Is Preferred in ALL High-risk AS Patients |
Alain G. Cribier |
May. 09. 13 |
1666 |
Counterpoint: PFO Clinical Trial Results (RESPECT and PC) Are Problematic |
Ted Feldman |
May. 09. 13 |
1665 |
Featured Lecture: The Aggressive Case for PFO Closure After Cryptogenic Stroke |
Bernhard Meier |
May. 09. 13 |
1664 |
Insight into Bioabsorbable Stent with Clinical and Imaging Outcomes |
Yoshinobu Onuma |
May. 09. 13 |
1663 |
Technical and Biological Challenges for Future DES Development |
Stephen G. Ellis |
May. 09. 13 |
1662 |
Xience-V Stent |
Charles A. Simonton |
May. 09. 13 |
1661 |
Endeavor Resolute Stent |
Hyo-Soo Kim |
May. 09. 13 |
1660 |
Promus-Element Stent |
Alan C. Yeung |
May. 09. 13 |